Cargando…
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
INTRODUCTION: Chronic nonbacterial osteomyelitis (CNO) is a rare autoinflammatory bone disorder primarily affecting children and adolescents. It can lead to chronic pain, bony deformities and fractures. The pathophysiology of CNO is incompletely understood. Scientific evidence suggests dysregulated...
Autores principales: | Ramanan, A. V., Hampson, L. V., Lythgoe, H, Jones, A. P., Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N, Davidson, J, Ferguson, P. J., Herlin, T, Kavirayani, A, Killeen, O. G., Compeyrot-Lacassagne, S, Laxer, R. M., Roderick, M, Swart, J. F., Hedrich, C. M., Beresford, M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550371/ https://www.ncbi.nlm.nih.gov/pubmed/31166977 http://dx.doi.org/10.1371/journal.pone.0215739 |
Ejemplares similares
-
Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO)
por: Zhao, Dan Yongdong, et al.
Publicado: (2021) -
PReS-FINAL-2229: Pamidronate in CRMO - a small case series
por: Schuller, M, et al.
Publicado: (2013) -
P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
por: Kostik, MM, et al.
Publicado: (2013) -
Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
por: Morbach, H, et al.
Publicado: (2015) -
Chronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate)
por: Teruzzi, B, et al.
Publicado: (2008)